Global RNA-Based Vaccines Sales Market Report 2018

Published On: Nov 2018

Format: PDF

Publisher: QY Research

Pages: 119

Report ID: 190278

In this report, the global RNA-Based Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNA-Based Vaccines for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global RNA-Based Vaccines market competition by top manufacturers/players, with RNA-Based Vaccines sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Type I
Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global RNA-Based Vaccines Sales Market Report 2018
1 RNA-Based Vaccines Market Overview
1.1 Product Overview and Scope of RNA-Based Vaccines
1.2 Classification of RNA-Based Vaccines by Product Category
1.2.1 Global RNA-Based Vaccines Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global RNA-Based Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3
1.2.4
1.3 Global RNA-Based Vaccines Market by Application/End Users
1.3.1 Global RNA-Based Vaccines Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA-Based Vaccines Market by Region
1.4.1 Global RNA-Based Vaccines Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States RNA-Based Vaccines Status and Prospect (2013-2025)
1.4.3 China RNA-Based Vaccines Status and Prospect (2013-2025)
1.4.4 Europe RNA-Based Vaccines Status and Prospect (2013-2025)
1.4.5 Japan RNA-Based Vaccines Status and Prospect (2013-2025)
1.4.6 Southeast Asia RNA-Based Vaccines Status and Prospect (2013-2025)
1.4.7 India RNA-Based Vaccines Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of RNA-Based Vaccines (2013-2025)
1.5.1 Global RNA-Based Vaccines Sales and Growth Rate (2013-2025)
1.5.2 Global RNA-Based Vaccines Revenue and Growth Rate (2013-2025)

2 Global RNA-Based Vaccines Competition by Players/Suppliers, Type and Application
2.1 Global RNA-Based Vaccines Market Competition by Players/Suppliers
2.1.1 Global RNA-Based Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global RNA-Based Vaccines Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global RNA-Based Vaccines (Volume and Value) by Type
2.2.1 Global RNA-Based Vaccines Sales and Market Share by Type (2013-2018)
2.2.2 Global RNA-Based Vaccines Revenue and Market Share by Type (2013-2018)
2.3 Global RNA-Based Vaccines (Volume and Value) by Region
2.3.1 Global RNA-Based Vaccines Sales and Market Share by Region (2013-2018)
2.3.2 Global RNA-Based Vaccines Revenue and Market Share by Region (2013-2018)
2.4 Global RNA-Based Vaccines (Volume) by Application

3 United States RNA-Based Vaccines (Volume, Value and Sales Price)
3.1 United States RNA-Based Vaccines Sales and Value (2013-2018)
3.1.1 United States RNA-Based Vaccines Sales and Growth Rate (2013-2018)
3.1.2 United States RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
3.1.3 United States RNA-Based Vaccines Sales Price Trend (2013-2018)
3.2 United States RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
3.3 United States RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
3.4 United States RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

4 China RNA-Based Vaccines (Volume, Value and Sales Price)
4.1 China RNA-Based Vaccines Sales and Value (2013-2018)
4.1.1 China RNA-Based Vaccines Sales and Growth Rate (2013-2018)
4.1.2 China RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
4.1.3 China RNA-Based Vaccines Sales Price Trend (2013-2018)
4.2 China RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
4.3 China RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
4.4 China RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

5 Europe RNA-Based Vaccines (Volume, Value and Sales Price)
5.1 Europe RNA-Based Vaccines Sales and Value (2013-2018)
5.1.1 Europe RNA-Based Vaccines Sales and Growth Rate (2013-2018)
5.1.2 Europe RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
5.1.3 Europe RNA-Based Vaccines Sales Price Trend (2013-2018)
5.2 Europe RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
5.3 Europe RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
5.4 Europe RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

6 Japan RNA-Based Vaccines (Volume, Value and Sales Price)
6.1 Japan RNA-Based Vaccines Sales and Value (2013-2018)
6.1.1 Japan RNA-Based Vaccines Sales and Growth Rate (2013-2018)
6.1.2 Japan RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
6.1.3 Japan RNA-Based Vaccines Sales Price Trend (2013-2018)
6.2 Japan RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
6.3 Japan RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
6.4 Japan RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia RNA-Based Vaccines (Volume, Value and Sales Price)
7.1 Southeast Asia RNA-Based Vaccines Sales and Value (2013-2018)
7.1.1 Southeast Asia RNA-Based Vaccines Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia RNA-Based Vaccines Sales Price Trend (2013-2018)
7.2 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

8 India RNA-Based Vaccines (Volume, Value and Sales Price)
8.1 India RNA-Based Vaccines Sales and Value (2013-2018)
8.1.1 India RNA-Based Vaccines Sales and Growth Rate (2013-2018)
8.1.2 India RNA-Based Vaccines Revenue and Growth Rate (2013-2018)
8.1.3 India RNA-Based Vaccines Sales Price Trend (2013-2018)
8.2 India RNA-Based Vaccines Sales Volume and Market Share by Players (2013-2018)
8.3 India RNA-Based Vaccines Sales Volume and Market Share by Type (2013-2018)
8.4 India RNA-Based Vaccines Sales Volume and Market Share by Application (2013-2018)

9 Global RNA-Based Vaccines Players/Suppliers Profiles and Sales Data
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 RNA-Based Vaccines Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 RNA-Based Vaccines Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Roche RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Sanofi-Aventis
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 RNA-Based Vaccines Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi-Aventis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Abbott Laboratories
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 RNA-Based Vaccines Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Abbott Laboratories RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Arrowhead Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 RNA-Based Vaccines Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Benitec Biopharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 RNA-Based Vaccines Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Benitec Biopharma RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Calimmune Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 RNA-Based Vaccines Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Calimmune Inc RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Dicerna
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 RNA-Based Vaccines Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Dicerna RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Gradalis
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 RNA-Based Vaccines Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Gradalis RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Quark
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 RNA-Based Vaccines Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Quark RNA-Based Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 RXi
9.12 Senesco
9.13 Silence Therapeutics
9.14 Silenseed
9.15 Tekmira
9.16 Alnylam Pharmaceuticals

10 RNA-Based Vaccines Maufacturing Cost Analysis
10.1 RNA-Based Vaccines Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of RNA-Based Vaccines
10.3 Manufacturing Process Analysis of RNA-Based Vaccines

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 RNA-Based Vaccines Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of RNA-Based Vaccines Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global RNA-Based Vaccines Market Forecast (2018-2025)
14.1 Global RNA-Based Vaccines Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global RNA-Based Vaccines Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global RNA-Based Vaccines Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global RNA-Based Vaccines Price and Trend Forecast (2018-2025)
14.2 Global RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global RNA-Based Vaccines Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global RNA-Based Vaccines Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 China RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 Europe RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India RNA-Based Vaccines Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global RNA-Based Vaccines Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global RNA-Based Vaccines Sales Forecast by Type (2018-2025)
14.3.2 Global RNA-Based Vaccines Revenue Forecast by Type (2018-2025)
14.3.3 Global RNA-Based Vaccines Price Forecast by Type (2018-2025)
14.4 Global RNA-Based Vaccines Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer